Market Overview

UPDATE: Abbott Posts Upbeat Q2 Profit

Share:
Related ABT
3 Companies That Could Be Negatively Impacted By Johnson & Johnson Sale Of Cordis
Mason Hawkins Likes Chemtura, Melco Crown; Doesn't Like Berkshire Hathaway
The Dividend House DGI Portfolio: The Good, The Bad, And The Ugly (Seeking Alpha)

Abbott Laboratories (NYSE: ABT) reported a drop in its second-quarter profit.

Abbott's quarterly profit fell to $476 million, or $0.30 per share, versus $1.73 billion, or $1.08 per share, in the year-earlier quarter. Its adjusted earnings from continuing operations surged to $0.46 per share from $0.43 per share.

Its net sales jumped 2.5% to $5.45 billion from $5.31 billion. However, analysts were projecting earnings of $0.44 per share on sales of $5.52 billion.

Abbott shares closed at $35.70 yesterday.

Posted-In: profitEarnings News

 

Related Articles (ABT)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→